Biodesix, Inc., a leading diagnostics solutions company, announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and ...
Abstract: Modern distributed system require self healing computational network in order to keep resilience, reliability and efficiency. However, this paper presents BISNet (bio inspired self healing ...
LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which ...
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colorado — October 22, 2025 — Biodesix, Inc., a leading diagnostics ...
Bio-Rad Laboratories Inc. reported its earnings for the second quarter of 2025, revealing a modest increase in net sales and a stable financial performance. Despite a challenging market environment, ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), and Gencurix, Inc. (KOSDAQ: 229000), announced the signing of a strategic agreement establishing Bio-Rad as the exclusive distributor of Gencurix’ ...
Abstract: Premature birth complications have different causes and vary in different parts of the world with sepsis as one of the leading causes of these complications. The body releases ...